Donanemab may offer new hope for people with early Alzheimer’s disease

FHS
July 17, 2023
5:44 pm

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important advancement in Alzheimer’s research and treatment.

Researchers Develop DNA Biosensor for Early Cervical Cancer Diagnosis

What You Should Know: Recently, researchers from Chung-Ang University developed an electrochemical DNA biosensor with enhanced sensitivity for effective HPV detection with high specificity. They

September 8, 2023

AHA asks Biden administration for relief amid IV fluid shortage from Hurricane Helene

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. The American Hospital Association is calling on

October 9, 2024

Discovery of TRPC5 gene’s role in obesity and postnatal depression offers hope for new treatments

Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioral problems and, in mothers, postnatal depression. The discovery, reported today in Cell,

July 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.